These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


301 related items for PubMed ID: 4613061

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Membrane syndrome (respiratory distress syndrome) in newborn infants. Pathogenesis and therapy with special regard to alveolar surface active agent].
    Keuth U.
    Fortschr Med; 1973 Jun 07; 91(16):693-7. PubMed ID: 4740218
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Anti-atelectasis factor (surfactant) and hyaline membrane disease in premature infants].
    Saule H.
    Med Klin; 1975 Mar 07; 70(10):409-15. PubMed ID: 1091827
    [No Abstract] [Full Text] [Related]

  • 6. [Comparative studies in adults and newborn infants on the pathogenesis of pulmonary hyaline membranes].
    Bleyl U.
    Verh Dtsch Ges Pathol; 1970 Mar 07; 54():340-8. PubMed ID: 4104562
    [No Abstract] [Full Text] [Related]

  • 7. Pulmonary hyaline membrane: sites of formation in adult lungs after assisted respiration and inhalation of oxygen.
    Barter RA, Finlay-Jones LR, Walters MN.
    J Pathol Bacteriol; 1968 Apr 07; 95(2):481-8. PubMed ID: 4870300
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Importance of the "surfactant system" in the pathogenesis of hyaline membrane in the newborn].
    Cosmi EV, Condorelli S, Scarpelli EM.
    Acta Anaesthesiol; 1970 Apr 07; 31():Suppl:69-94. PubMed ID: 5538013
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Nil nocere. Lung damage following intensive infusion and oxygen treatment as well as a contribution on the incidence of hyaline membranes in alveoli in adults].
    Hambach R.
    Munch Med Wochenschr; 1966 Feb 25; 108(8):424-6. PubMed ID: 5299018
    [No Abstract] [Full Text] [Related]

  • 16. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment].
    Uszyńska-Folejewska R, Uszyński M.
    Pediatr Pol; 1977 Dec 25; 52(12):1413-7. PubMed ID: 343058
    [No Abstract] [Full Text] [Related]

  • 17. [Prevention of respiratory distress in premature infants through pernatal treatment with betamethasone].
    Di Meglio L, Furbatto G, Gallo G, Vercellotti E.
    Minerva Ginecol; 1979 Dec 25; 31(7-8):557-62. PubMed ID: 481813
    [No Abstract] [Full Text] [Related]

  • 18. The circulation, fluid transfers and surface activity in the lungs of infants with hyaline membrane disease.
    Normand IC.
    Bull Physiopathol Respir (Nancy); 1973 Dec 25; 9(6):1473-94. PubMed ID: 4602246
    [No Abstract] [Full Text] [Related]

  • 19. Exogenous surfactant administration during the transport of premature infants.
    Riek KM.
    Air Med J; 2004 Dec 25; 23(5):8-9. PubMed ID: 15337930
    [No Abstract] [Full Text] [Related]

  • 20. [The surface tension properties of the lungs of newborn babies. Investigations from autopsies on stillborn and premature infants and babies dying from hyaline membrane disease 'respiratory distress' syndrome].
    Baum M, Benzer H, Lempert J, Regele H, Stühlinger W, Tölle W.
    Respiration; 1971 Dec 25; 28(5):409-28. PubMed ID: 5171707
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.